
    
      This project intends to observation of bleeding the application of antiplatelet in patients
      with CAA, so as to provide effective clinical evidence for the further application of
      clopidogrel and aspirin in patients with CAA in the future, and to provide reference basis
      for the accurate formulation of clinical treatment plans and the balance of health risks
      brought by adverse bleeding reactions.
    
  